Research FDA peptide votes could open the door to more unproven drugs: ‘Pandora’s box’By Healthcare Propulsion StaffJuly 25, 20260 A Food and Drug Administration advisory committee on Friday recommended allowing two more unproven peptides to be compounded, capping a…
Research ‘Rescheduling’ cannabis would ease restrictions on science, opening the door to the largest investment in cannabis research we’ve seen to date | Raymond PalidoraBy Healthcare Propulsion StaffJuly 24, 20260 There has been talk of “rescheduling” cannabis for years, a regulatory move that would significantly ease federal restrictions on the…
